Skip to Content

RE 287 (Darcalma hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate

Pill imprint RE 287 has been identified as Darcalma hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg.

Darcalma is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darcalma hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Darcalma
Generic Name:
hyoscyamine/methenamine/methylene blue/phenyl salicylate
Imprint:
RE 287
Strength:
hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg
Color:
Blue
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
River's Edge Pharmaceuticals, LLC

More info Print Imprint Search

More about Darcalma (hyoscyamine / methenamine / methylene blue / phenyl salicylate)

Consumer resources

Professional resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide